Ameriprise’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-402,963
| Closed | -$592K | – | 3951 |
|
|
2023
Q4 | $592K | Sell |
402,963
-60,678
| -13% | -$89.2K | ﹤0.01% | 3384 |
|
|
2023
Q3 | $561K | Sell |
463,641
-4,319
| -0.9% | -$5.23K | ﹤0.01% | 3363 |
|
|
2023
Q2 | $679K | Buy |
+467,960
| New | +$679K | ﹤0.01% | 3323 |
|
|
2022
Q2 | – | Sell |
-586,642
| Closed | -$5.1M | – | 3987 |
|
|
2022
Q1 | $5.1M | Buy |
586,642
+223,108
| +61% | +$1.94M | ﹤0.01% | 2413 |
|
|
2021
Q4 | $5.82M | Sell |
363,534
-13,561
| -4% | -$217K | ﹤0.01% | 2365 |
|
|
2021
Q3 | $6.94M | Sell |
377,095
-61,742
| -14% | -$1.14M | ﹤0.01% | 2150 |
|
|
2021
Q2 | $6.13M | Buy |
438,837
+4,049
| +0.9% | +$56.5K | ﹤0.01% | 2303 |
|
|
2021
Q1 | $6.4M | Buy |
434,788
+169,347
| +64% | +$2.49M | ﹤0.01% | 2234 |
|
|
2020
Q4 | $5.15M | Buy |
+265,441
| New | +$5.15M | ﹤0.01% | 2252 |
|
|
2020
Q3 | – | Sell |
-21,454
| Closed | -$290K | – | 3777 |
|
|
2020
Q2 | $290K | Buy |
+21,454
| New | +$290K | ﹤0.01% | 3375 |
|